Clinical Trial Update: Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating subcutaneous immunotherapy for birch pollen allergy was terminated; the update discusses efficacy and safety observations in allergic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Staloral birch pollen extract (birch pollen subcutaneous immunotherapy)

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergy | Phase 2 | Status: TERMINATED